1. Guidance D. Chronic hepatitis B virus infection: developing drugs for treatment guidance for industry chronic hepatitis B virus infection: developing drugs for treatment guidance for industry. FDA; 2018:1–24. Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm. Accessed July 07, 2023.
2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
3. Molecular biology of hepatitis B virus infection
4. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec. 2017;92(27):369–392.